Ra Medical Systems, Inc. (RMED)

NYSEAMERICAN: RMED · IEX Real-Time Price · USD
1.06 -0.10 (-8.62%)
Jan 21, 2022 4:00 PM EST - Market closed

Total Valuation

RMED has a market cap or net worth of $7.45 million. The enterprise value is -$10.81 million.

Market Cap7.45M
Enterprise Value-10.81M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

RMED has 7.03 million shares outstanding. The number of shares has increased by 168.86% in one year.

Shares Outstanding7.03M
Shares Change (YoY)+168.86%
Shares Change (QoQ)+56.88%
Owned by Insiders (%)8.18%
Owned by Institutions (%)9.16%
Float6.50M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio2.23
PB Ratio0.35
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 6.56, with a Debt / Equity ratio of 0.11.

Current Ratio6.56
Quick Ratio5.94
Debt / Equity0.11
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -137.70%, which is considered low. The company has a ROIC of -416.10%.

Return on Equity (ROE)-137.70%
Return on Assets (ROA)-94.80%
Return on Capital (ROIC)-416.10%
Revenue Per Employee$49,925
Profits Per Employee-$406,373
Employee Count67
Asset Turnover0.12
Inventory Turnover2.46

Taxes

In the past 12 months, RMED has paid $7,000 in taxes.

Income Tax7,000
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -86.30% in the last 52 weeks. The beta is 1.39, so RMED's price volatility has been higher than the market average.

Beta (1Y)1.39
52-Week Price Change-86.30%
50-Day Moving Average1.59
200-Day Moving Average2.73
Average Volume (30 Days)191,308

Short Selling Information

Short Interest476,500
Short % of Shares Out6.78%
Short % of Float7.33%
Short Ratio (days to cover)2.48

Income Statement

In the last 12 months, RMED had revenue of $3.35 million and -27.23 million in losses. Earnings per share was -$6.66.

Revenue3.35M
Gross Profit-1.08M
Operating Income-32.21M
Pretax Income-27.22M
Net Income-27.23M
EBITDA-25.31M
EBIT-27.08M
Earnings Per Share (EPS)-$6.66
Full Income Statement

Balance Sheet

The company has $20.62 million in cash and $2.36 million in debt, giving a net cash position of $18.26 million or $2.60 per share.

Cash & Cash Equivalents20.62M
Total Debt2.36M
Net Cash18.26M
Net Cash Per Share$2.60
Book Value21.55M
Book Value Per Share3.07
Working Capital19.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.33 million and capital expenditures $335,000, giving a free cash flow of -$30.99 million.

Operating Cash Flow-31.33M
Capital Expenditures335,000
Free Cash Flow-30.99M
FCF Per Sharen/a
Full Cash Flow Statement

Margins

Gross margin is -32.14%, with operating and profit margins of -962.78% and -813.96%.

Gross Margin-32.14%
Operating Margin-962.78%
Pretax Margin-813.75%
Profit Margin-813.96%
EBITDA Margin-756.74%
EBIT Margin-809.66%
FCF Margin-926.55%

Dividends & Yields

RMED does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-365.39%
FCF Yield-415.93%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on November 17, 2020. It was a reverse split with a ratio of 1:25.

Last Split DateNov 17, 2020
Split TypeReverse
Split Ratio1:25